IGC Pharma (IGC) Other Operating Expenses (2014 - 2017)
IGC Pharma (IGC) reported Other Operating Expenses of -$757260.0 for Q1 2017, down 0.65% year-over-year from -$762232.5 in Q1 2016, and down 576.37% quarter-over-quarter from -$111960.0 in Q4 2016.
IGC Pharma (IGC) Other Operating Expenses (2014 - 2017) Analysis & Trends
IGC Pharma (IGC) has 4 years of Other Operating Expenses data on file, last reported at -$757260.0 in Q1 2017.
- Other Operating Expenses for Q1 2017 came in at -$757260.0, down 0.65% year-over-year; the trailing twelve-month figure through Dec 2017 was -$757260.0 (up 59.34% YoY), and the FY2017 annual result was -$1.9 million, up 12.64% from the prior year.
- Other Operating Expenses eased to -$757260.0 in Q1 2017 per IGC's latest filing, from -$111960.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at -$111960.0 in Q4 2016 and troughed at -$1.2 million in Q2 2014.
- A 4-year average of -$632031.3 and a median of -$652988.0 in 2015 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 83.81% in 2016 and fell as far as 97.69% in 2016.
- A 4-year view of Other Operating Expenses shows it stood at -$593845.0 in 2014, then retreated by 16.44% to -$691502.0 in 2015, then jumped by 83.81% to -$111960.0 in 2016, then slumped by 576.37% to -$757260.0 in 2017.
- Business Quant data shows IGC's Other Operating Expenses at -$757260.0 in Q1 2017, -$111960.0 in Q4 2016, and -$614474.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -757,260.00 |
| Dec 31, 2016 | -111,960.00 |
| Sep 30, 2016 | -614,474.00 |
| Jun 30, 2016 | -383,566.00 |
| Mar 31, 2016 | -752,352.00 |
| Dec 31, 2015 | -691,502.00 |
| Sep 30, 2015 | -310,829.00 |
| Jun 30, 2015 | -382,669.00 |
| Mar 31, 2015 | -888,176.00 |
| Dec 31, 2014 | -593,845.00 |
| Sep 30, 2014 | -903,977.00 |
| Jun 30, 2014 | -1.19 Mn |